This purposeful interaction involving the serotoninergic and central dopaminergic programs continues to be shown in experiments with haloperidol, a D2 receptor antagonist that attenuates the psychotomimetic effects of psilocybin [five].The regulations pertaining to psilocybin in New Hampshire are not any unique than These from the nation within the